CIK 0001699382 · Non-accelerated filer<br>Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463218129
- Phone
- (609) 642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2023-06-08 | FLOWERS KIRSTEN Director | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2023-06-08 | BAUM CHARLES M Director | Grant or award · Stock Option (right to buy) | +21,500 | 21,500 | ||
| 2023-05-12 | Jalota Deepika Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-12 | Alland Leila Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-05-12 | Kung Winston COO, CFO | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-05-12 | Mack David Henry President and CEO | Grant or award · Employee Stock Option (right to buy) | +330,000 | 330,000 | ||
| 2022-11-25 | Kung Winston COO, CFO | Gift | −2,560 | 10,600 | ||
| 2022-11-05 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | −39,000 | 39,000 | ||
| 2022-11-05 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | +39,000 | 39,000 | ||
| 2022-11-04 | Gallagher Carol Giltner Director | Grant or award · Stock Option (right to buy) | +39,000 | 39,000 | ||
| 2022-09-09 | Jalota Deepika SVP, Regulatory Affairs and QA | Grant or award | +34,050 | 34,050 | ||
| 2022-09-09 | Alland Leila Chief Medical Officer | Grant or award | +52,200 | 52,200 | ||
| 2022-06-02 | Stelzer Laurie Director | Grant or award · Stock Option | −19,500 | 19,500 | ||
| 2022-06-02 | LEVINE ARNOLD J Director | Grant or award · Stock option (right to buy) | +19,500 | 19,500 | ||
| 2022-06-02 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +19,500 | 19,500 | ||
| 2022-06-02 | FLOWERS KIRSTEN Director | Grant or award · Stock Option (right to buy) | +19,500 | 19,500 | ||
| 2022-06-02 | BAUM CHARLES M Director | Grant or award · Stock Option (right to buy) | +19,500 | 19,500 | ||
| 2022-05-26 | ORBIMED ADVISORS LLC 10% owner | Sale | −26,253 | $15.93 | $418K | 87,786 |
| 2022-04-27 | Mack David Henry President and CEO | Option exercise | +33,000 | $0.53 | $17K | 79,970 |
Page 5 of 10 · 196 trades